Pfizer (PFE) FCF Margin (QoQ) (2009 - 2026)
Pfizer (PFE) FCF Margin (QoQ) (2009 - 2026) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 653.03 Bn | 632.27 Bn | 17.26 Bn |
| 2 | AbbVie | 469.62 Bn | 463.05 Bn | 12.70 Bn |
| 3 | Merck | 375.00 Bn | 367.85 Bn | 12.21 Bn |
| 4 | Novartis Ag | 303.31 Bn | 295.62 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.68 Bn | 252.78 Bn | 12.86 Bn |
| 6 | Amgen | 236.34 Bn | 222.35 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 182.09 Bn | 178.91 Bn | 6.22 Bn |
| 8 | Pfizer | 159.43 Bn | 147.73 Bn | 10.94 Bn |
| 9 | Gsk | 106.25 Bn | 102.08 Bn | 8.24 Bn |
| 10 | Sanofi | 55.19 Bn | 47.81 Bn | 10.79 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 28, 2026 | -1,307.00 |
| Mar 29, 2026 | 2,767.00 |
| Dec 31, 2025 | -3,662.00 |
| Sep 28, 2025 | 7,682.00 |
| Jun 29, 2025 | -6,571.00 |
| Sep 29, 2024 | 3,152.00 |
| Jun 30, 2024 | -2,533.00 |
| Mar 31, 2024 | -11,960.00 |
| Jul 2, 2023 | -6,281.00 |
| Jul 3, 2022 | 376.00 |
| Oct 3, 2021 | -1,293.00 |
| Jul 4, 2021 | 2,950.00 |
| Sep 27, 2020 | 189.00 |
| Jun 28, 2020 | 556.00 |
| Sep 29, 2019 | 1,504.00 |
| Jun 30, 2019 | 664.00 |
| Mar 31, 2019 | -34,649.00 |
| Dec 31, 2018 | 32,050.00 |
| Sep 30, 2018 | 1,001.00 |
| Jul 1, 2018 | 1,305.00 |